NEW YORK (GenomeWeb) — Genomic sequencing business incubator Murrieta Genomics has agreed to promote SeqOnce Biosciences' next-generation sequencing sample prep technology, the companies announced today.
SeqOnce was founded in 2014 as a spinout of the University of Southern California and has developed a technology called RhinoSeq for NGS library preparation that the Pasadena-based company says is significantly quicker than competing methods.
Under the terms of the deal, Murrieta will provide information and demonstrations on RhinoSeq to potential customers at its incubator facility in Murietta, California, as well as test additional SeqOnce products in its laboratory to assist in their development. Additional terms were not disclosed.
"We see RhinoSeq reducing library construction time from a multi-hour process to less than 45 minutes, producing consistently excellent results across a wide range of sample types and inputs," Murrieta Cofounder and Director of Laboratory Operations Brandon Young said in a statement. "We are excited to team with SeqOnce to develop, showcase, and demonstrate their libraries to our growing base of customers and incubator companies."
About a year ago, SeqOnce closed a $1 million seed financing round. In December, Murrieta partnered with genomics blockchain startup EncrypGen.